Novel mutations causing hyperimmunoglobulin d and periodic fever syndrome

[1]  T. Heike,et al.  [Hyperimmunoglobulinemia D and periodic fever syndrome]. , 2011, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[2]  H. Waterham,et al.  Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up , 2008, Clinical Rheumatology.

[3]  J. Drenth,et al.  Hyperimmunoglobulinaemia D syndrome in India: report of two siblings with a novel mutation , 2006, Annals of the rheumatic diseases.

[4]  H. Waterham,et al.  Mutational spectrum and genotype–phenotype correlations in mevalonate kinase deficiency , 2006, Human mutation.

[5]  H. Waterham,et al.  Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. , 2006, Arthritis and rheumatism.

[6]  P. Hawkins,et al.  Hereditary auto-inflammatory disorders and biologics , 2006, Springer Seminars in Immunopathology.

[7]  G. Hoffmann,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[8]  H. Waterham,et al.  Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation , 2003, Cellular and Molecular Life Sciences CMLS.

[9]  J. Drenth,et al.  Hereditary periodic fever. , 2001, The New England journal of medicine.

[10]  M. Daha,et al.  Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.

[11]  K. Sartor,et al.  Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. , 1993, Pediatrics.